A searchable database of
medically documented cases

About the Project

Spontaneous Resolution Of Residual Shunting In 2 Compromised Patients After Amplatzer Occlusion Of Postinfarction Ventricular Septal Defects

Yanagiuchi, T. 2019Other/Unknown

Yanagiuchi, T., Tada, N., Suchi, T., Mizutani, Y., Matsumoto, T., Sakurai, M., & Ootomo, T. (2019). Spontaneous Resolution of Residual Shunting in 2 Compromised Patients after Amplatzer Occlusion of Postinfarction Ventricular Septal Defects. Texas Heart Institute journal, 46(1), 44–47. https://doi.org/10.14503/THIJ-17-6416

View Original Source →

Abstract

Ventricular septal defect (VSD) is a rare, potentially fatal complication of acute myocardial infarction. When surgical closure is contraindicated, transcatheter closure may be an alternative. Residual shunting after transcatheter closure of postinfarction VSDs has been reported; however, we found few cases of this in patients who also had severe heart failure or hemolysis. We report 2 closures of postinfarction VSDs with use of the Amplatzer Septal Occluder. Both elderly patients-one with severe heart failure, one with persistent hemolysis, and neither a surgical candidate-had high-velocity residual shunting through the occluders. We intensively managed the patients' conditions and used angiography and transthoracic echocardiography to record the gradual disappearance of each shunt over 4 months-the first such serial monitoring of which we are aware. We think that even substantial shunting in the presence of severe heart failure or hemolysis can eventually resolve spontaneously, assuming effective management of the concomitant medical conditions.

Case Details

Disease Location

Heart (interventricular septa)

Personal Characteristics

77-year-old woman

Clinical Characteristics

Diagnosed with ventricular septal rupture after a subacute anteroseptal mi. The defect was 11 mm in diameter, with thin surrounding tissue. 28 days after admission, she underwent transcatheter closure of the defect with a 20-mm amplatzer septal occluder (aso). Intra-aortic balloon pump (iabp) support and anticoagulant and antiplatelet medications were started. Tte and left ventriculogram showed small residual shunts. Tte on postoperation day 2 revealed increasing left-to-right shunt flow through the lower half of the aso hoping to promote thrombosis inside the aso the anticoagulant and antiplatelet therapy were discontinued. Diuretic therapy was added (15 mg/d of tolvaptan, stopped on pod 50)

Remission Characteristics

At 4 months, the shunt flow disappeared

Treatment & Mechanisms

Proposed Remission Mechanisms

Healing response to the occludes over time.

Clinical Treatment

Intra-aortic balloon pump anticoagulant and antiplatelet medications transcatheter closure